GLP-1 Cost Calculator
Prices are the manufacturers' own published cash prices and program terms, last checked 2026-09-04 — not scraped live, and not specific to any pharmacy or insurer. This tool doesn't sell or refer to any provider.
This is a general price snapshot, not a quote — actual pharmacy pricing, your specific insurance plan, dose, and availability can all differ from these manufacturer-published figures. Confirm current pricing with your pharmacy, insurer, or the manufacturer's own program directly before making a decision. Upcoming: Novo Nordisk has announced that the list prices of Wegovy, Ozempic and Rybelsus drop to $675 on Jan 1, 2027; the company says this does not change its direct-to-patient self-pay prices. Prices shown are the Sept 4, 2026 snapshot; the Mounjaro $499, Wegovy pill $149 and Zepbound KwikPen figures could not be re-confirmed on Oct 3.
Compare official manufacturer-published GLP-1 prices (Wegovy, Ozempic, Mounjaro, Zepbound) across cash-pay, insurance-with-savings-card, and Medicare Bridge — no lead form, no referral to any provider.
How it works
- Pick a medication (Wegovy injection, Wegovy pills, Ozempic, Mounjaro, or Zepbound)
- Pick a payment path (manufacturer direct cash pay, insurance with a savings card, or the Medicare GLP-1 Bridge)
- See the manufacturer-published monthly and annual cost, or an honest note when no official price is confirmed for that combination
Frequently asked questions
Why do some combinations show 'Not confirmed' instead of a price?
Not every medication has a publicly stated price for every payment path — for example, the Medicare GLP-1 Bridge program only covers Wegovy and Zepbound, not Ozempic or Mounjaro. Rather than guess, this tool says so directly.
Are any price changes coming?
Novo Nordisk has announced that the list price of Wegovy, Ozempic and Rybelsus falls to $675 on January 1, 2027 (roughly 50% lower for Wegovy and 35% for Ozempic). The company states this does not affect its direct-to-patient self-pay prices, which is what the cash-pay figures here reflect. Insurance and Medicare pricing may change from 2027, so re-check this tool then.
Are these real-time prices?
No — these are manufacturer-published cash prices and program terms as of 2026-09-04, not a live feed. Actual pharmacy pricing, your specific insurance plan, and dose can all differ. Confirm current pricing with your pharmacy, insurer, or the manufacturer directly.
Does this tool sell GLP-1 prescriptions or coaching?
No. Several existing GLP-1 cost calculators are run by companies that sell their own prescribing or coaching service and ask for income or insurance details before showing a price. This tool doesn't sell anything or collect any personal information — it just shows the publicly published numbers.
Related tools
Update history
- 2026-10-03 Added the announced Jan 1, 2027 Novo Nordisk list-price cut to $675 (self-pay unchanged per Novo); clarified Zepbound self-pay wording (published $299-$449 vial prices, KwikPen at the same self-pay price per Lilly) and flagged figures not re-confirmed.
- 2026-09-04 Launched: GLP-1 medication cost calculator comparing manufacturer-published prices across payment paths (cash pay, insurance + savings card, Medicare Bridge), with an explicit price-snapshot date instead of live scraping. Entirely client-side.